BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12453770)

  • 41. Botox injections for gummy smiles.
    Niamtu J
    Am J Orthod Dentofacial Orthop; 2008 Jun; 133(6):782-3; author reply 783-4. PubMed ID: 18538226
    [No Abstract]   [Full Text] [Related]  

  • 42. BOTOX therapy for every dental practice.
    Malcmacher L
    Dent Today; 2009 Aug; 28(8):114, 116-7. PubMed ID: 19715075
    [No Abstract]   [Full Text] [Related]  

  • 43. [Neuromuscular blockade with botulinum toxin. From toxin to therapeutic agent].
    Einecke D
    MMW Fortschr Med; 2001 May; 143 Suppl 2():95-6. PubMed ID: 11434276
    [No Abstract]   [Full Text] [Related]  

  • 44. The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation.
    Kane MA
    Facial Plast Surg; 2005 Feb; 21(1):55-64. PubMed ID: 15988657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG; Dover J; Glogau RG; Goldberg DJ; Goldman MP; Schlessinger J
    J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the patient for cosmetic Botox injections.
    Dayan SH; Bassichis BA
    Facial Plast Surg Clin North Am; 2003 Aug; 11(3):349-58. PubMed ID: 15062263
    [No Abstract]   [Full Text] [Related]  

  • 47. Complications with the use of botulinum toxin type a in facial rejuvenation: report of 8 cases.
    Ferreira MC; Salles AG; Gimenez R; Soares MF
    Aesthetic Plast Surg; 2004; 28(6):441-4. PubMed ID: 15580431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type A botulinum toxin in the upper aspect of the face.
    Hexsel D; Dal'forno T
    Clin Dermatol; 2003; 21(6):488-97. PubMed ID: 14759582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of botulinum toxin type A in the upper face.
    Carruthers J; Carruthers A
    Facial Plast Surg Clin North Am; 2006 Aug; 14(3):253-60. PubMed ID: 16908393
    [No Abstract]   [Full Text] [Related]  

  • 51. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Facial anatomy and botulinum toxin: the muscular balances].
    Trevidic P; Cauchois R; Ingallina F
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of clostridium botulinum: a neurotoxin in clinical dermatology.
    Matarasso SL
    West J Med; 1998 Oct; 169(4):226. PubMed ID: 9795588
    [No Abstract]   [Full Text] [Related]  

  • 54. Botox for the eyes and eyebrows.
    Klein AW
    Dermatol Clin; 2004 Apr; 22(2):145-9, vi. PubMed ID: 15222574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single transcutaneous injection with Botox for dysthyroid lid retraction.
    Shih MJ; Liao SL; Lu HY
    Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuralgic amyotrophy following botulinum toxin injection.
    Alcalay RN; Simões RM; Feigin A; Frucht S
    Parkinsonism Relat Disord; 2010 May; 16(4):301-2. PubMed ID: 19815448
    [No Abstract]   [Full Text] [Related]  

  • 57. Contraindications and complications with the use of botulinum toxin.
    Klein AW
    Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width.
    Wu WT
    Facial Plast Surg Clin North Am; 2010 Feb; 18(1):133-40. PubMed ID: 20206096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin type A for the treatment of glabellar rhytides.
    Carruthers A; Carruthers J
    Dermatol Clin; 2004 Apr; 22(2):137-44. PubMed ID: 15222573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.